SCHEMBL9130593

SCHEMBL9130593

N=C(c1ccccc1O)c1ccccc1O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 8/20 0.52
KDM4E B2RXH2 6/20 0.52
ALDH1A1 P00352 6/20 0.52
SMN1; SMN2 Q16637 3/20 0.52
CA12 O43570 2/20 0.52
CA2 P00918 2/20 0.52
CA4 P22748 2/20 0.52
CA14 Q9ULX7 2/20 0.52
CA1 P00915 1/20 0.52
HMGB1 P09429 1/20 0.52
CA6 P23280 1/20 0.52
CA7 P43166 1/20 0.52
CA9 Q16790 1/20 0.52
NAPRT Q6XQN6 1/20 0.52
HSD17B10 Q99714 6/20 0.50
MAPT P10636 4/20 0.50
LMNA P02545 4/20 0.50
NPC1 O15118 3/20 0.50
ALOX15 P16050 3/20 0.50
HIF1A Q16665 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8346552 0.97 HPGD (0.50) HPGDKDM4EALDH1A1SMN1; SMN2CA12
SCHEMBL50746 0.85 HPGD (0.50) HPGDKDM4EALDH1A1SMN1; SMN2CA12
SCHEMBL29132386 0.81 LIG1 (0.59) HPGDKDM4EALDH1A1SMN1; SMN2CA12
SCHEMBL7196261 0.81 TRIM24 (0.63) HPGDKDM4EALDH1A1SMN1; SMN2CA12
SCHEMBL51671 0.78 KMT2A (0.56) HPGDKDM4EALDH1A1SMN1; SMN2CA12
SCHEMBL4711338 0.78 HPGD (0.48) HPGDKDM4EALDH1A1SMN1; SMN2CA12
SCHEMBL30525835 0.78 HPGD (0.48) HPGDKDM4EALDH1A1SMN1; SMN2CA12
SCHEMBL652876 0.78 KDM4E (0.58) HPGDKDM4EALDH1A1SMN1; SMN2CA12
SCHEMBL3519397 0.78 MAOB (0.45) HPGDKDM4EALDH1A1SMN1; SMN2CA12
SCHEMBL7184700 0.76 HPGD (0.57) HPGDKDM4EALDH1A1SMN1; SMN2CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5421897-A Applying liquid composition to surface contaminated with lead, solidifying into matrix which sequesters lead, removing matrix GRAWE JOHN (US) 1995-06-06 US claimed
US-11185853-B2 Catalysts for polycarbonate production SAUDI ARAMCO TECHNOLOGIES COMPANY (SA) 2021-11-30 US disclosed
CN-106103121-B Encrypted optical marker for security applications 亚普蒂恩(B.V.I.)公司 2019-12-06 CN disclosed
US-20190193062-A1 CATALYSTS FOR POLYCARBONATE PRODUCTION ARAMCO PERFORMANCE MATERIALS LLC 2019-06-27 US disclosed
US-9850223-B2 Metal catalysts for selective formation of cyclic carbonates, process for preparing cyclic carbonate using the same and use of cyclic carbonate KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2017-12-26 US disclosed
US-9850223-B2 Metal catalysts for selective formation of cyclic carbonates, process for preparing cyclic carbonate using the same and use of cyclic carbonate KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2017-12-26 US disclosed
US-20170081302-A1 METAL CATALYSTS FOR SELECTIVE FORMATION OF CYCLIC CARBONATES, PROCESS FOR PREPARING CYCLIC CARBONATE USING THE SAME AND USE OF CYCLIC CARBONATE KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2017-03-23 US disclosed
US-20170081302-A1 METAL CATALYSTS FOR SELECTIVE FORMATION OF CYCLIC CARBONATES, PROCESS FOR PREPARING CYCLIC CARBONATE USING THE SAME AND USE OF CYCLIC CARBONATE KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2017-03-23 US disclosed
CN-106103121-A Encrypting optical label for safety applications 亚普蒂恩(B.V.I.)公司 2016-11-09 CN disclosed
US-5421897-A Applying liquid composition to surface contaminated with lead, solidifying into matrix which sequesters lead, removing matrix GRAWE JOHN (US) 1995-06-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170081302-A1 METAL CATALYSTS FOR SELECTIVE FORMATION OF CYCLIC CARBONATES, PROCESS FOR PREPARING CYCLIC CARBONATE USING THE SAME AND USE OF CYCLIC CARBONATE CA2, TMCO1, CA1 HPGD 645/4885KDM4E 1427/4885ALDH1A1 3222/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.